首页> 美国卫生研究院文献>Contemporary Clinical Trials Communications >Study protocol for assessing the user acceptance safety and efficacy of a tablet-based workflow and decision support system with incorporated basal insulin algorithm for glycaemic management in participants with type 2 diabetes receiving home health care: A single-centre open-label uncontrolled proof-of-concept study
【2h】

Study protocol for assessing the user acceptance safety and efficacy of a tablet-based workflow and decision support system with incorporated basal insulin algorithm for glycaemic management in participants with type 2 diabetes receiving home health care: A single-centre open-label uncontrolled proof-of-concept study

机译:评估基于片剂的工作流程和决策支持系统的用户验收安全性和功效的研究方案其参与者在接受家庭医疗保健的参与者中纳入基础胰岛素算法用于接受家庭保健的2型糖尿病:单中心开放标签不受控制概念证明研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diabetes management can be especially complex for older adults who receive health care at home. Thus, international guidelines recommend basal-insulin regimens due to simpler handling and low hypoglycaemia risk. A basal-insulin algorithm (including basal-plus) was developed to also include participant's health status and subsequently implemented into a tablet-based workflow and decision support system, GlucoTab@MobileCare. This study protocol describes a proof-of-concept study to investigate user acceptance, safety and efficacy of the GlucoTab@MobileCare system in participants receiving home health care.
机译:对于在家接受医疗保健的老年人来说,糖尿病管理可能尤其复杂。因此,国际指南推荐基底胰岛素方案,因为处理更简单,低血糖风险低。基础胰岛素算法(包括Basal-Plus)是开发的,也包括参与者的健康状况,随后实施到基于平板电脑的工作流程和决策支持系统,Glucotab @ Mobilecare。本研究方案描述了概念证据,以调查接受家庭医疗保健的参与者的葡萄球@ Mobilecare系统的用户验收,安全性和有效性。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号